Autor/es: Nicolas Fissolo, Béatrice Pignolet, Clara MatuteBlanch, Juan Carlos Triviño, Berta Miró, Miriam Mota, Santiago PérezHoyos, Alex Sanchez, Patrick Vermersch, Aurélie Ruet, Jérome de Sèze, Pierre Labauge, Sandra Vukusic, Caroline Papeix, Laurent Almoyna, Ayman Tourbah, Pierre Clavelou, Thibault Moreau, Jean Pelletier, Christine LebrunFrenay, Xavier Montalban, David Brassat, Manuel Comabella on Behalf of BIONAT, BEST-MS and SFSEP network

MMP9 is decreased in natalizumab-treated MS patients at risk for PML

http://onlinelibrary.wiley.com/doi/10.1002/ana.24987/full

Download PDF